Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist PegvisomantPeter Trainer, John A. Scarlett, William M Drake et al.|New England Journal of Medicine|2000Cited by 874
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonistAart Jan van der Lely, Michael O. Thorner, R. Kent Hutson et al.|The Lancet|2001Cited by 643
Long-Term Mortality after Transsphenoidal Surgery and Adjunctive Therapy for Acromegaly<sup>1</sup>Brooke Swearingen, Nicholas T. Zervas, Fred G. Barker et al.|The Journal of Clinical Endocrinology & Metabolism|1998Cited by 587
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An UpdateAndrea Giustina, Шломо Мелмед, Diego Ferone et al.|The Journal of Clinical Endocrinology & Metabolism|2019Cited by 363
Consensus on diagnosis and management of Cushing's disease: a guideline updateMaria Fleseriu, John Wass, Richard J. Auchus et al.|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2021Cited by 351